| http://www.w3.org/ns/prov#value | - Secunda says a study done by AdvaMed in conjunction with the Accenture consulting group found a direct marking requirement would cost the industry billions of dollars because of the need to purchase specific manufacturing equipment, including software and systems associated with linking the device and packaging with the UDI. Beyond the cost issue, direct marking of implants adds more risk than be
|
